# Naari Pharma Private Limited – FDA Inspection, Nov 1, 2025

Source: https://www.keypedia.com/records/fda_inspections/naari-pharma-private-limited/bc58b578-1b32-4a13-8e44-0868d734ea74
Source feed: FDA_Inspections

> FDA inspection 1289782 of Naari Pharma Private Limited, November 01, 2025. 4 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1289782
- Company Name: Naari Pharma Private Limited
- Inspection Date: 2025-11-01
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 4

## Related Documents

- [FDA Inspection 1198458 - 2023-01-27](https://www.keypedia.com/records/fda_inspections/naari-pharma-private-limited/c07e4653-53b3-42a4-b91a-fe13d1c6c44d)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/rafeeq-a-habeeb/ac58c0b7-bd42-4037-8ccb-bf0351b7744f)

Company: https://www.keypedia.com/companies/naari-pharma-private-limited/1c2f99e8-3cb0-4ae1-ab3a-d3daf65f1595

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
